Investigating how a specific protein affects cocaine cravings during withdrawal
Role of PL CaMKII in incubated cocaine-craving
This study is looking at how certain brain chemicals affect cravings for cocaine when someone is trying to stay away from it, and it hopes to find new ways to help people who are dealing with cocaine addiction.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Santa Barbara NIH-funded |
| Lab location | 1 site (Santa Barbara, United States) |
| Project ID | NIH-11075682 on NIH RePORTER |
What this research studies
This research focuses on understanding the neurochemical mechanisms behind cocaine cravings, particularly during periods of abstinence. It examines the role of calcium-calmodulin-dependent protein kinase II (CaMKII) in the medial prefrontal cortex, which is believed to influence drug-seeking behavior. By using animal models, the study aims to uncover how activation of this protein correlates with increased cravings for cocaine, potentially leading to better treatment strategies for those struggling with cocaine use disorder.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a history of cocaine use disorder who are currently in a state of abstinence.
Not a fit: Patients who have not used cocaine or those with other substance use disorders unrelated to cocaine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic approaches for reducing cocaine cravings and preventing relapse in individuals with cocaine use disorder.
How similar studies have performed: While the specific role of CaMKII in cocaine craving has not been extensively studied, related research has shown success in understanding the neurochemical basis of addiction and cravings.
Where this research is happening
Santa Barbara, United States
- University of California Santa Barbara — Santa Barbara, United States (Active)
Researchers
- Principal investigator: Huerta Sanchez, Laura — University of California Santa Barbara
- Study coordinator: Huerta Sanchez, Laura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.